Gastric Endocrine Cell Proliferation and Fundic Argyrophil Carcinoid Tumors in Patients with the Zollinger-Ellison Syndrome

References

• Mignon M, Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol 1988; 2: 677–98
   PubMedGoogle Scholar
• Bordi C, Cocconi G, Togni R, Vezzadini P, Missale G. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol 1974; 98: 274–8
   PubMedGoogle Scholar
• Carney J A, Go V L, Fairbanks V F, Moore S B, Alport E C, Nora F E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 1983; 99: 761–6
   PubMed Web of Science ®Google Scholar
• Mignon M, Lehy T, Bonnefond A, Ruszniewski P, Labeille D, Bonfils S. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer 1987; 59: 1959–62
   PubMed Web of Science ®Google Scholar
• Lehy T, Mignon M, Cadiot G, et al. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 1989; 96: 1029–40
   PubMed Web of Science ®Google Scholar
• Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 1990; 14: 503–13
   PubMed Web of Science ®Google Scholar
• Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992; 33: 1275–9
   PubMed Web of Science ®Google Scholar
• Solcia E, Fiocca R, Sessa F, . Morphology and natural history of gastric endocrine tumors. The stomach as an endocrine organ, R Hakanson, F Sundler, et al. Elsevier, Amsterdam 1991; 473–98
   Google Scholar
• Cadiot G, Lehy T, Ruszniewski P, Bonfils S. Mignon M. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment, Dig Dis Sci (in press)
   Google Scholar
• Maton P N, Lack E E, Collen M J, et al. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. Gastroenterology 1990; 99: 943–50
   PubMed Web of Science ®Google Scholar
• Helander H F. Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome. Digestion 1986; 35(Suppl. 1)123–9
   PubMedGoogle Scholar
• Bardram L, Thomsen P, Stadil F. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome. Digestion 1986; 35(35)116-22
   PubMedGoogle Scholar
• Hage E, Hendel L, Bardram L, Gustafsen J, Hendel J. Stentoft P. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole. Gastroenterology 1991; 100: A79
   Google Scholar
• D'Adda T., Bertele A, Pilato F P, Bordi C. Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res 1989; 255: 41–8
   PubMedGoogle Scholar
• Simonsson M, Eriksson S, Hakanson R, et al. Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol 1988; 23: 1089–99
   PubMed Web of Science ®Google Scholar
• D'Adda T, Corleto V, Pilato F P, et al. Quantitative ultra-structure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology 1990; 99: 17–26
   PubMed Web of Science ®Google Scholar
• Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988; 41: 185–200
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G, Andersen B N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21: 357–63
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Mattsson H. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391–9
   PubMed Web of Science ®Google Scholar
• Bardram L. Gastroenterology 1990; 98: 1420–6
   PubMed Web of Science ®Google Scholar
• Ryberg B, Bishop A E, Bloom S R, et al. Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach. Regul Pept 1989; 25: 235–46
   PubMedGoogle Scholar
• Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(20)53–69
   Google Scholar
• Helander H F, Simonsson M, Sundler F, Rutgersson K, Helander K G, Eriksson S. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole of H2-receptor antagonists. Virchows Arch [A] 1990; 417: 305–9
   Google Scholar
• Green D M, Bishop A E, Rindi G, et al. Enterochromaffin-like cell populations in human fundic mucosa: quantitative studies of their variations with age, sex, and plasma gastrin levels. J Pathol 1989; 157: 235–41
   PubMed Web of Science ®Google Scholar
• Friedman E, Sakagushi K, Bale A E, et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 1989; 321: 213–6
   PubMed Web of Science ®Google Scholar
• Thakker R V, Bouloux P, Wooding C, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosomes 11. N Engl J Med 1989; 321: 218–24
   PubMed Web of Science ®Google Scholar